According to Satsuma Pharmaceuticals's latest financial reports the company's current EPS (TTM) is NZ-$3.40. In 2022 the company made an earnings per share (EPS) of NZ-$3.70 a decrease over its 2021 EPS that were of NZ-$2.99.